On December 11th, I gave a talk at the 2024 ESMO Immuno-Oncology Congress during an educational session co-chaired with Marco Donia, discussing the real-world benefits of immunotherapy. This is the talk, recorded live during one of our regular VKPrasad Lab meetings! It's followed by a lively and engaging discussion and Q&A session. I hope you will enjoy!
RANDOMIZED versus REAL-WORLD EVIDENCE ON THE EFFICACY AND TOXICITY OF CHECKPOINT INHIBITORS.
This is a talk I presented at the ESMO Immuno-Oncology 2024 Congress, recorded live with Vinay Prasad and the VKPrasad Lab team, followed by an engaging Q&A session!
The Drug Development Letter
Share this post